Cathy Burton

1.7k total citations · 1 hit paper
38 papers, 848 citations indexed

About

Cathy Burton is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, Cathy Burton has authored 38 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 11 papers in Surgery. Recurrent topics in Cathy Burton's work include Lymphoma Diagnosis and Treatment (21 papers), Viral-associated cancers and disorders (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Cathy Burton is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Viral-associated cancers and disorders (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Cathy Burton collaborates with scholars based in United Kingdom, Czechia and United States. Cathy Burton's co-authors include R. N. White, Eve Roman, Russell Patmore, Alexandra Smith, Simon Crouch, Fintan J. McEvoy, Sharon Barrans, Debra Howell, Reuben Tooze and Daniel Painter and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Epidemiology.

In The Last Decade

Cathy Burton

35 papers receiving 836 citations

Hit Papers

Targeted sequencing in DLBCL, molecular subtypes, and out... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report
    2020 260 citations Stuart Lacy, Sharon Barrans et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathy Burton United Kingdom 16 479 304 209 182 142 38 848
Monica Morselli Italy 19 331 0.7× 327 1.1× 275 1.3× 181 1.0× 106 0.7× 47 1.2k
Oumédaly Reman France 20 362 0.8× 385 1.3× 87 0.4× 236 1.3× 141 1.0× 61 1.4k
S Pileri Italy 17 449 0.9× 337 1.1× 119 0.6× 212 1.2× 354 2.5× 36 1.3k
F Silvestri Italy 17 301 0.6× 332 1.1× 85 0.4× 269 1.5× 329 2.3× 41 941
Carlos Grande Spain 18 504 1.1× 622 2.0× 78 0.4× 206 1.1× 32 0.2× 82 1.4k
Byeong Seok Sohn South Korea 14 290 0.6× 268 0.9× 195 0.9× 67 0.4× 31 0.2× 55 673
Armando López‐Guillermo Spain 8 440 0.9× 338 1.1× 113 0.5× 267 1.5× 51 0.4× 10 1.5k
Alessandra Sperotto Italy 22 293 0.6× 378 1.2× 94 0.4× 343 1.9× 68 0.5× 55 1.5k
Muhammad Ali Saudi Arabia 20 188 0.4× 210 0.7× 300 1.4× 57 0.3× 38 0.3× 71 948
Marina Mošunjac United States 20 337 0.7× 269 0.9× 297 1.4× 80 0.4× 18 0.1× 59 1.0k

Countries citing papers authored by Cathy Burton

Since Specialization
Citations

This map shows the geographic impact of Cathy Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Burton more than expected).

Fields of papers citing papers by Cathy Burton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Burton. The network helps show where Cathy Burton may publish in the future.

Co-authorship network of co-authors of Cathy Burton

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Burton. A scholar is included among the top collaborators of Cathy Burton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Burton. Cathy Burton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chaganti, Sridhar, Christopher P. Fox, Cathy Burton, et al.. (2025). Management of relapsed or refractory large B‐cell lymphoma: A British Society for Haematology Guideline. British Journal of Haematology. 206(6). 1593–1603. 2 indexed citations
3.
4.
Fox, Christopher P., Sridhar Chaganti, Graham McIlroy, et al.. (2024). The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline. British Journal of Haematology. 204(4). 1178–1192. 8 indexed citations
5.
Lamb, Maxine, Daniel Painter, Debra Howell, et al.. (2023). Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK’s Haematological Malignancy Research Network. Cancer Epidemiology. 88. 102513–102513. 10 indexed citations
6.
Holmes, Matthew, Gina B. Scott, Victoria A. Jennings, et al.. (2023). Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells. Molecular Therapy — Oncolytics. 29. 17–29. 4 indexed citations
7.
Crouch, Simon, Daniel Painter, Sharon Barrans, et al.. (2022). Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network. Blood Advances. 6(21). 5716–5731. 17 indexed citations
8.
Frood, Russell, Matthew Clark, Cathy Burton, et al.. (2022). Discovery of Pre-Treatment FDG PET/CT-Derived Radiomics-Based Models for Predicting Outcome in Diffuse Large B-Cell Lymphoma. Cancers. 14(7). 1711–1711. 20 indexed citations
9.
Frood, Russell, Matthew D. Clark, Cathy Burton, et al.. (2022). Utility of pre-treatment FDG PET/CT–derived machine learning models for outcome prediction in classical Hodgkin lymphoma. European Radiology. 32(10). 7237–7247. 18 indexed citations
10.
Martínez‐Calle, Nicolás, Amy A. Kirkwood, Maxine Lamb, et al.. (2021). Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort. Advances in Therapy. 38(7). 3789–3802. 3 indexed citations
11.
Lacy, Stuart, Sharon Barrans, Philip Beer, et al.. (2020). Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood. 135(20). 1759–1771. 260 indexed citations breakdown →
12.
13.
Burton, Cathy, et al.. (2020). Histiocytic sarcoma of the base of tongue treated with radical radiotherapy: A case report and review of the literature. Clinical and Translational Radiation Oncology. 21. 66–68. 6 indexed citations
14.
Smith, Alexandra, Eve Roman, Simon Appleton, et al.. (2018). Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN). British Journal of Haematology. 181(2). 215–228. 32 indexed citations
15.
Roman, Eve, Simon Crouch, Eline Aas, et al.. (2018). A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population–Based Observational Data. Value in Health. 21(10). 1176–1185. 14 indexed citations
16.
Aas, Eline, et al.. (2016). Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort. The European Journal of Health Economics. 18(2). 255–267. 17 indexed citations
17.
Smith, Alexandra, Simon Crouch, Debra Howell, et al.. (2015). Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma. Cancer Epidemiology. 39(6). 1103–1112. 38 indexed citations
18.
Gow, Adam G., Cathy Burton, Roger M. Powell, et al.. (2014). Hepatic Hepcidin Gene Expression in Dogs with a Congenital Portosystemic Shunt. Journal of Veterinary Internal Medicine. 28(4). 1203–1205. 9 indexed citations
19.
Grierson, J., Cathy Burton, & M. J. Brearley. (2003). Hypertrophic osteopathy secondary to pulmonary sarcoma in a cat. Veterinary and Comparative Oncology. 1(4). 227–231. 14 indexed citations
20.
Burton, Cathy & R. N. White. (1999). The angiographic anatomy of the portal venous system in the neonatal dog. Research in Veterinary Science. 66(3). 211–217. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Morselli Breakdown of academic impact, for papers by Oumédaly Reman Breakdown of academic impact, for papers by S Pileri Breakdown of academic impact, for papers by F Silvestri Breakdown of academic impact, for papers by Carlos Grande Breakdown of academic impact, for papers by Byeong Seok Sohn Breakdown of academic impact, for papers by Armando López‐Guillermo Breakdown of academic impact, for papers by Alessandra Sperotto Breakdown of academic impact, for papers by Muhammad Ali Breakdown of academic impact, for papers by Marina Mošunjac
Rankless by CCL
2026